Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Undefined

ABSTRACT: Detection of an IMI-2 Carbapenemase-Producing Enterobacter asburiae at a Feed Processing Plant in Sweden

PROVIDER: PRJEB53023 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR9827840.fastq.gz	Fastqsanger.gz
	ERR9827841.fastq.gz	Fastqsanger.gz
	ERR9827842.fastq.gz	Fastqsanger.gz
	ERR9827843_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Enterobacter asburiae

Project description:FRI-5 carbapenemase-producing Enterobacter asburiae WGS

| PRJDB8412 | ENA

Enterobacter asburiae

Project description:Whole genome sequencing of FRI-9 carbapenemase-producing Enterobacter asburiae

| PRJDB18650 | ENA

undefined

Project description:Dissemination of Carbapenemase-producing Enterobacterales through outlet water and gulls at a wastewater treatment plant in Sweden

| PRJEB58069 | ENA

Project description:Global carbapenemase-producing Enterobacter spp

| PRJNA398291 | ENA

Proteomics analysis of the Enterobacter cloacae response to imipenem

Project description:Recently, we have reported on a highly drug-resistant carbapenemase-producing isolate of Enterobacter cloacae (Nepal et al., Virulence. 2018; 9: 1377-1389). In the present study, we asked the question whether and, if so, how this isolate responds to a sub-inhibitory challenge with the antibiotic imipenem. To answer this question, we applied a SILAC proteomics approach that allowed the quantification of changes in the relative abundance of bacterial protein in response to imipenem. The results show that the investigated E. cloacae isolate mounts a highly specific response to counteract the detrimental effects of imipenem.

2021-08-10 | PXD013412 | Pride

Enterobacter cloacae complex

Project description:Carbapenemase-producing Enterobacter cloacae complex WGS

| PRJDB6828 | ENA

Project description:Epidemiology of IMI-type-carbapenemase-producing E. cloacae complex in France

| PRJNA1015552 | ENA

Clinical Evaluation of Advanced MALDI-TOF MS for Carbapenemase Subtyping in Gram-negative Isolates

Project description:The spread of carbapenemase-producing Enterobacterales (CPE) is emerging as a significant clinical concern in tertiary hospitals and in particular, long-term care facilities with deficiencies in infection control. This study aims to evaluate an advanced matrix-assisted laser desorption/ionization mass spectrometry (A-MALDI) method for the identification of carbapenemases and further discrimination of their subtypes in clinical isolates. The A-MALDI method was employed to detect CPE target proteins. Enhancements were made to improve detectability and mass accuracy through the optimization of MALDI-TOF settings and internal mass calibration. A total of 581 clinical isolates were analyzed, including 469 CPE isolates (388 KPC, 51 NDM, 40 OXA, and 2 GES) and 112 carbapenemase-negative isolates. Clinical evaluation of the A-MALDI demonstrated 100% accuracy and precision in identifying all the collected CPE isolates. Additionally, A-MALDI successfully discriminated individual carbapenemase subtypes (KPC-2 or KPC-3/4; OXA-48 or OXA-181 or OXA-232; GES-5 or GES-24) and also differentiated co-producing carbapenemase strains (KPC & NDM; KPC & OXA; KPC & GES; NDM & OXA), attributed to its high mass accuracy and simultaneous detection capability. A-MALDI is considered a valuable diagnostic tool for accurately identifying CPE and carbapenemase’s subtypes in clinical isolates. It may also aid in selecting appropriate antibiotics for each carbapenemase subtype. Ultimately, we expect that the A-MALDI method will contribute to preventing the spread of antibiotic resistance and improving human public health.

2024-11-26 | PXD058284 | Pride

Enterobacter asburiae

Project description:Enterobacter asburiae overview

| PRJNA41519 | ENA

Project description:XDR Enterobacter asburiae

| PRJNA1043153 | ENA